Found: 30
Select item for more details and to access through your institution.
Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 729, doi. 10.1007/s00280-011-1583-2
- By:
- Publication type:
- Article
Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 741, doi. 10.1007/s00280-010-1342-9
- By:
- Publication type:
- Article
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 751, doi. 10.1007/s00280-010-1372-3
- By:
- Publication type:
- Article
Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 765, doi. 10.1007/s00280-010-1373-2
- By:
- Publication type:
- Article
Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 769, doi. 10.1007/s00280-010-1349-2
- By:
- Publication type:
- Article
Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 775, doi. 10.1007/s00280-010-1375-0
- By:
- Publication type:
- Article
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 783, doi. 10.1007/s00280-010-1381-2
- By:
- Publication type:
- Article
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 791, doi. 10.1007/s00280-010-1382-1
- By:
- Publication type:
- Article
Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 799, doi. 10.1007/s00280-010-1378-x
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 809, doi. 10.1007/s00280-010-1380-3
- By:
- Publication type:
- Article
Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 813, doi. 10.1007/s00280-010-1387-9
- By:
- Publication type:
- Article
Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 823, doi. 10.1007/s00280-010-1385-y
- By:
- Publication type:
- Article
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 829, doi. 10.1007/s00280-010-1384-z
- By:
- Publication type:
- Article
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 837, doi. 10.1007/s00280-010-1379-9
- By:
- Publication type:
- Article
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 847, doi. 10.1007/s00280-010-1360-7
- By:
- Publication type:
- Article
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 855, doi. 10.1007/s00280-010-1388-8
- By:
- Publication type:
- Article
Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 867, doi. 10.1007/s00280-010-1386-x
- By:
- Publication type:
- Article
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 875, doi. 10.1007/s00280-010-1376-z
- By:
- Publication type:
- Article
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 891, doi. 10.1007/s00280-010-1383-0
- By:
- Publication type:
- Article
2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
- Published in:
- 2011
- By:
- Publication type:
- journal article
2-Deoxy- d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 899, doi. 10.1007/s00280-010-1391-0
- By:
- Publication type:
- Article
Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 911, doi. 10.1007/s00280-010-1371-4
- By:
- Publication type:
- Article
Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 919, doi. 10.1007/s00280-010-1394-x
- By:
- Publication type:
- Article
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 927, doi. 10.1007/s00280-010-1389-7
- By:
- Publication type:
- Article
Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 935, doi. 10.1007/s00280-010-1392-z
- By:
- Publication type:
- Article
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 945, doi. 10.1007/s00280-010-1377-y
- By:
- Publication type:
- Article
A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- Report
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 963, doi. 10.1007/s00280-010-1476-9
- By:
- Publication type:
- Article
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia.
- Published in:
- 2011
- By:
- Publication type:
- letter
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter